Biopure (BPUR) Receives Nasdaq Delisting Notice
More News related to BPUR
- Biopure (BPUR) Receives Delisting Notification From NASDAQ
- Biopure (BPUR) Receives Nasdaq Delisting Notice
- Biopure (BPUR) Sees Upside Action
- Biopure (BPUR) Hires Newbury Piret & Co. to Help Explore Strategic Options
- FDA Advises US Navy That It May Not Initiate A Clinical Trial of Biopure's Product Hemopure
More News related to Corporate News
- Dendreon (DNDN) CEO Says Provenge Salesforce Will Be 125 People, Sees Full Manufacturing Ability by Mid-2011
- IBM (IBM) Signs 5-Year Remote Managed Services Agreement with Sandhar Technologies
- Google Unveils 'Buzz' Social Sharing Tool
- Semiconductor Manufacturing Int (SMI) Confirms Seeking Alternatives for Company; No Definite Decision Made
- Highlights From KO's Q4 Conference Call: Continued Solid Growth Globally in Several Segments
Biopure Corporation (Nasdaq: BPUR) announced that it has received notice from The Nasdaq Stock Market, by letter dated June 24, 2009, that it is out of compliance with the Nasdaq Marketplace Rules and its common stock may be delisted. The notice stated that the company no longer meets the minimum of $2,500,000 in stockholders' equity for continued listing on the Nasdaq Capital Market.
Nasdaq advised that the company has 15 calendar days to submit a plan to regain compliance. If such plan is accepted, Nasdaq may grant an extension of up to 105 days from the date of notification to regain compliance. If the Company is unable to regain compliance its common stock will be delisted. The company does not intend to submit a plan to regain compliance.
Related Categories
Corporate NewsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
